Carbidopa 4.63 MG/ML / levodopa 20 MG/ML Oral Suspension [Duopa] — RxCUI 1599852
RxNorm drug concept · Semantic branded drug
RxCUI 1599852
Semantic branded drug · SBD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1599852
Official nameCarbidopa 4.63 MG/ML / levodopa 20 MG/ML Oral Suspension [Duopa]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known ascarbidopa 4.63 MG/ML / L-DOPA 20 MG/ML Oral Suspension [Duopa]; Duopa 4.63 MG / 20 MG in 1 mL Enteral Suspension; Duopa (carbidopa 4.63 MG/ML (as carbidopa monohydrate 5 MG/ML) / levodopa 20 MG/ML) Enteral Suspension
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)128 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Levodopa and Carbidopa: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Levodopa is the medicine that actually works in your brain — it crosses into the brain and gets converted into dopamine, the chemical that Parkinson's disease depletes. The problem...
- What exactly does levodopa and carbidopa do, and why do I need both?
- Generally yes, but the timing and content of your meals can matter. High-protein foods — like large servings of meat, eggs, or dairy — can compete with levodopa for absorption in y...
- Can I eat normally while taking this medication?
🕸️ Concept Web — How Carbidopa 4.63 MG/ML / levodopa 20 MG/ML Oral Su... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Carbidopa 4.63 MG/ML / levodopa 20 MG/ML Oral Suspension [Duopa]
RxCUI 1599852 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 3
The active substance itself — no strength, form, or brand attached yet.
-
Carbidopa
2019IN -
Levodopa
6375IN -
Carbidopa / levodopa
103990MIN
-
Carbidopa
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Duopa
1599847BN
-
Duopa
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Carbidopa / levodopa Oral Suspension
1599845SCDF -
Carbidopa / levodopa Oral Liquid Product
1599844SCDG -
Carbidopa / levodopa Oral Product
1155774SCDG -
Carbidopa / levodopa Oral Suspension [Duopa]
1599849SBDF -
Duopa Oral Liquid Product
1599850SBDG -
Duopa Oral Product
1599851SBDG -
Oral Suspension
316969DF -
Oral Liquid Product
1151137DFG - +1 more in this family
-
Carbidopa / levodopa Oral Suspension
-
Clinical & branded drugs 4
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Carbidopa 4.63 MG/ML / levodopa 20 MG/ML Oral Suspension
1599846SCD -
Carbidopa 4.63 MG/ML
1599842SCDC -
Levodopa 20 MG/ML
1599843SCDC -
Carbidopa 4.63 MG/ML / levodopa 20 MG/ML [Duopa]
1599848SBDC
-
Carbidopa 4.63 MG/ML / levodopa 20 MG/ML Oral Suspension
Showing up to 8 concepts per family — 16 of 17 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Carbidopa 4.63 MG/ML / levodopa 20 MG/ML Oral Suspension
SCD · 1599846 -
Carbidopa 4.63 MG/ML
SCDC · 1599842 -
Levodopa 20 MG/ML
SCDC · 1599843 -
Carbidopa / levodopa Oral Suspension
SCDF · 1599845 -
Carbidopa / levodopa Oral Liquid Product
SCDG · 1599844 -
Carbidopa / levodopa Oral Product
SCDG · 1155774
Brand-Name Concepts
-
Carbidopa 4.63 MG/ML / levodopa 20 MG/ML [Duopa]
SBDC · 1599848 -
Carbidopa / levodopa Oral Suspension [Duopa]
SBDF · 1599849 -
Duopa Oral Liquid Product
SBDG · 1599850 -
Duopa Oral Product
SBDG · 1599851 -
Duopa
BN · 1599847
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 1599852 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00074-3012-07 | 7 CARTRIDGE in 1 CARTON (0074-3012-07) / 100 mL in 1 CARTRI... | Duopa | AbbVie Inc. | 2015-01-15 |
Observed labelers:
AbbVie Inc. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J7340 | Carbidopa levodopa ent 100ml | 1 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.